About the speaker: Dina Justice serves as the VP of Regulatory Affairs at Terumo Medical Corporation, directing US and global regulatory activities. With 17 years at the FDA, including roles as a reviewer and branch chief, Dina brings deep expertise. She holds a BS in Biomedical Engineering from The Catholic University of America and an MBA from the University of Maryland.

About the company:  Terumo Medical Corporation, backed by over a century of Terumo Corporation’s expertise, has evolved from a modest product range to expansive offerings across four divisions. Terumo Interventional Systems (TIS) specializes in entry site management and lesion access solutions. Terumo Medical Products (TMP) provides devices for injection and infusion therapy. Terumo Pharmaceutical Solutions (TPS) develops drug delivery devices. Terumo Health Outcomes (THO) offers care pathway consulting and precision medicine software for enhanced patient outcomes and operational efficiency.

Number of Employees: 30,000

Revenue: 4.65B